Drug Type Fusion protein |
Synonyms- |
Target |
Mechanism F10 stimulants(Coagulation factor X stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
RegulationBreakthrough Therapy (CN) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemophilia A | Phase 3 | US | 23 Feb 2021 | |
Hemophilia A | Phase 3 | US | 23 Feb 2021 | |
Hemophilia A | Phase 3 | BE | 23 Feb 2021 | |
Hemophilia A | Phase 3 | BE | 23 Feb 2021 | |
Hemophilia A | Phase 3 | BG | 23 Feb 2021 | |
Hemophilia A | Phase 3 | BG | 23 Feb 2021 | |
Hemophilia A | Phase 3 | BG | 23 Feb 2021 | |
Hemophilia A | Phase 3 | CA | 23 Feb 2021 | |
Hemophilia A | Phase 3 | CA | 23 Feb 2021 | |
Hemophilia A | Phase 3 | DE | 23 Feb 2021 |